Purple Biotech (PPBT) Depreciation & Amortization - Total (2017 - 2026)
Purple Biotech (PPBT) reported Depreciation & Amortization - Total of $65000.0 for Q1 2026, up 44.44% year-over-year from $45000.0 in Q1 2025, and up 44.44% on a QoQ basis from $45000.0 in Q1 2025.
Purple Biotech (PPBT) has 2 years of Depreciation & Amortization - Total data on file, last reported at $65000.0 in Q1 2026.
- Quarterly Depreciation & Amortization - Total rose 44.44% year-over-year to $65000.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $110000.0 (up 144.44% YoY) and the FY2025 annual result came in at $203000.0, up 9.14% from the prior year.
- Depreciation & Amortization - Total improved to $65000.0 in Q1 2026 per PPBT's latest filing, from $45000.0 in the prior quarter.
- Across five years, Depreciation & Amortization - Total topped out at $65000.0 in Q1 2026 and bottomed at $45000.0 in Q1 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Dep. & Amort. (Tot) (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | - |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | - |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | - |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | - |
| 10 | Purple Biotech | 3.58 Bn | 3.57 Bn | - | 65,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 65,000.00 |
| Dec 31, 2025 | 53,000.00 |
| Sep 30, 2025 | 58,000.00 |
| Jun 30, 2025 | 47,000.00 |
| Mar 31, 2025 | 45,000.00 |
| Dec 31, 2024 | 40,000.00 |
| Sep 30, 2024 | 49,000.00 |
| Jun 30, 2024 | 49,000.00 |
| Mar 31, 2024 | 48,000.00 |
| Dec 31, 2023 | 48,000.00 |
| Sep 30, 2023 | 50,000.00 |
| Jun 30, 2023 | 53,000.00 |
| Mar 31, 2023 | 46,000.00 |
| Dec 31, 2022 | 50,000.00 |
| Sep 30, 2022 | 47,000.00 |
| Jun 30, 2022 | 53,000.00 |
| Mar 31, 2022 | 51,000.00 |
| Dec 31, 2021 | 61,000.00 |
| Sep 30, 2021 | 63,000.00 |
| Jun 30, 2021 | 61,000.00 |
| Mar 31, 2021 | 46,000.00 |
| Dec 31, 2020 | 143,000.00 |
| Dec 31, 2019 | 84,000.00 |
| Dec 31, 2018 | 4,000.00 |
| Dec 31, 2017 | 2,000.00 |